Skip to main content

Daniel V Araujo, MD

Oncologist (Cancer Specialist)

Rated 4.8 out of 5 stars
Additional languages:
Portuguese
Photo of Daniel V Araujo

Research at a glance

Top areas of exploration

  • Neoplasms , 8 publications
  • Melanoma , 5 publications
  • Circulating Tumor DNA , 5 publications
  • Biomarkers, Tumor , 5 publications

Research activity

38 publications

734 citations

Why is this important?

Active clinical trials

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

This phase III trial compares the effect of adding live biotherapy, MO-03, to standard of care (SOC) immunotherapy, including ipilimumab, nivolumab, axitinib, pembrolizumab, cabozantinib, and lenvatinib, to SOC immunotherapy alone in treating…

Investigator
Daniel V Araujo
Status
Accepting Candidates
Ages
Adults
Sexes
All

My publications

38 publications

2026

Role of Postoperative Radiation Therapy After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis.

Advances in radiation oncology

PubMed • Publisher's site

2026

Case Report: Metastatic melanoma with initial ctdna decline and radiographic response during self-directed antiparasitic use: treatment effect or spontaneous regression?

Frontiers in oncology

PubMed • Publisher's site

2026

Seasonal Patterns and Implications of Cancer Diagnosis Across Calendar Months.

JAMA network open

PubMed • Publisher's site

2026

Durable benefits, but no improvements in overall survival: what can we learn from CheckMate 238 after 9 years of follow-up?

Translational cancer research

PubMed • Publisher's site